New oral testosterone pill studied for men with kidney disease
NCT ID NCT05249634
First seen Apr 30, 2026 · Last updated May 22, 2026 · Updated 5 times
Summary
This study is for men aged 18-85 with both low testosterone and chronic kidney disease. Researchers want to see if an oral testosterone medication called JATENZO can safely raise testosterone levels and improve red blood cell counts, muscle strength, and sexual function. The study involves 20 participants and includes blood tests, hand-grip strength measurements, and body scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DISEASE, CHRONIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Saint Louis Univeristy
RECRUITINGSt Louis, Missouri, 63104, United States
Contact
Conditions
Explore the condition pages connected to this study.